Skip to main content
MOH logo

MOH · Molina Healthcare, Inc.

Track MOH — free
$196.94 -4.23 (-2.10%) At close · Aug 20
Market Cap
$10.50B
Shares
52.20M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$196.94 Open$200.13 Day$196.80–202.47 52W close$122.65–242.88 Avg vol 30d1.2M Short int2.9M · 5.6% float · 1.4d Short vol48% Last earningsJul 23, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 23

Up next

Next earnings call
Oct 22, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 23, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Fair Quant / Vol Very High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +13%
      above
      Price vs 50-day avg −6%
      below
      RSI (14) 43
      neutral
      MACD trend Positive
      52-week position 62%
      mid-range
      Momentum
      relative strength
      Very Strong
      1-month return −2%
      trailing
      6-month return +28%
      trailing
      YTD return +13%
      this year
      Relative strength +17%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $211 › 200d $174 — 50d above 200d
      Institutional flow Accumulating
      +13% holders QoQ · +154 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      5.62% of float · ▼ -12.0% MoM · 1.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      600 holders — mid 3-yr range
      Squeeze score 53
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth +12%
      Y/Y
      Gross margin 5%
      contracting
      EPS growth −56%
      Y/Y
      Free cash flow $-636.0M
      Buyback $2.0B
      authorized
      Balance sheet $482.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 53%
      annualized · 1-yr
      Max drawdown −40%
      past year
      ATR 4.1%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 1 of last 3
      Latest guidance · from the 8-K filed Jul 22, 2026
      Premium revenue · full year 2026 at least $42B
      GAAP earnings · full year 2026 at least $2.15
      Adjusted earnings · full year 2026 at least $5.25
      Prior guidance period ended · from the 8-K filed Oct 22, 2025
      Premium Revenue · Full Year 2025 $42.5B
      GAAP Net Income · Full Year 2025 $630M
      Adjusted EPS – Diluted · Full Year 2025 $14.00
      GAAP EPS – Diluted · Full Year 2025 $11.90
      Adjusted Net Income · Full Year 2025 $742M
      MCR · Full Year 2025 91.3%
      Medicaid MCR · Full Year 2025 91.5%
      Marketplace MCR · Full Year 2025 89.7%
      Adjusted G&A Ratio · Full Year 2025 6.5%
      GAAP G&A Ratio · Full Year 2025 6.6%
      Medicare MCR · Full Year 2025 91.3%
      GAAP Pre-tax Margin · Full Year 2025 1.8%
      Effective Tax Rate · Full Year 2025 21.7%
      Adjusted Pre-tax Margin · Full Year 2025 2.1%
      Guided vs delivered · last 3 settled
      GAAP EPS – Diluted Full Year 2025
      guided $11.90
      $8.92 Miss −25.0%
      Adjusted earnings per share 2024 full year
      guided at least $23.50
      $20.42 Miss −13.1%
      Premium revenue 2024
      guided $38B
      $40.65B Beat +7.0%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +13% Bullish
      Price vs 50-day avg
      −6% Bearish
      RSI (14)
      43 Neutral
      MACD trend
      Positive Bullish
      52-week position
      62% Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $211 › 200d $174 — 50d above 200d
      Institutional flow Accumulating
      +13% holders QoQ · +154 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      5.62% of float · ▼ -12.0% MoM · 1.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      600 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $123 Now $197 · 62% Range high $243
      vs 200-day avg +13% vs 50-day avg -6%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted net income non-GAAP $197M Six Months Ended June 30, 2026
      Adjusted net income per diluted share non-GAAP $3.86 Six Months Ended June 30, 2026
      Marketplace MCR 86.3% Six Months Ended June 30, 2026
      Marketplace Membership 283,000 As of June 30, 2026
      Medicaid MCR 92.4% Six Months Ended June 30, 2026
      Medicaid Membership 4,418,000 As of June 30, 2026
      Medicare Membership 224,000 As of June 30, 2026
      Total Membership 4,926,000 As of June 30, 2026
      MCR 94.6% Three months ended December 31, 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Healthcare Plans — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      MOH
      Molina Healthcare, Inc.
      this stock
      $10.50B +13.5% +11.7% 5.6%
      UNH
      Unitedhealth Group Inc
      $345.44B +16.6% +11.8% 1.7%
      CVS
      CVS HEALTH Corp
      $119.95B +18.0% +7.8% 24.8 1.5%
      ELV
      Elevance Health, Inc.
      $87.01B +13.0% +12.5% 17.8 2.6%
      CI
      Cigna Group
      $74.37B -0.3% +11.2% 11.7 1.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      600
      % held
      110.5%
      Net QoQ
      +685.7K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      465
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      2.9M
      Days to cover
      1.4d
      Change
      -398.9K sh
      View
      Short Volume
      Short vol %
      48%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      52.7K
      Value
      $10.6M
      As of
      Jul 29, 2026
      View
      Off-Exchange
      Off-exchange %
      44.7%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Gilbert Cisneros
      Amount
      $1.0K–$15.0K
      Traded
      Nov 12, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $45.4B
      Net income (FY)
      $472.0M
      EPS diluted
      $8.92
      View
      Buybacks
      Authorized · 2 programs
      $2.0B
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Jul 23, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $114.9K
      Shares
      600
      Filed
      May 14, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 23, 2026
      View
      Investor Relations
      Latest news
      Molina Healthcare Reports Second…
      Published
      Jul 22, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      MOH -4.3% -1.7% +27.8% +0.7% +13.5%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY -2.3% -5.0% +16.7% -1.4% +1.7%

      Capital returns

      Buyback programs · 2 active · as of Apr 30, 2025
      Authorized (total)
      $2.00B
      Spent (derived)
      Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1179929 CUSIP 60855R100 13F (30d) 548 filings 519 filers Visit website Investor relations